Metaniff HT Cream is a dermatologist-recommended triple-action topical formulation that combines the benefits of a depigmenting agent, a corticosteroid, and a retinoid. It is primarily indicated for the short-term treatment of melasma and other types of hyperpigmentation. This unique blend of Hydroquinone, Mometasone, and Tretinoin works synergistically to lighten dark patches, reduce inflammation, and promote skin cell turnover for a more even skin tone and healthier complexion.
-
Hydroquinone is a skin-lightening agent that inhibits the enzyme tyrosinase, preventing melanin production. It helps fade dark spots, sun damage, and melasma-related pigmentation.
-
Mometasone Furoate, a potent corticosteroid, reduces redness, swelling, and inflammation associated with melasma or irritation caused by other skin-lightening treatments.
-
Tretinoin, a derivative of Vitamin A, increases cell turnover, smooths the skin, and enhances the penetration and effectiveness of Hydroquinone while also reducing fine lines and surface roughness.
This combination is widely used in dermatology for its powerful effect on stubborn pigmentation issues, especially on the face. It is advised to use Metaniff HT Cream only under medical supervision due to the strength of its active ingredients and their potential to cause irritation if misused.
Apply a thin layer of the cream to the affected area once daily at night or as directed by your physician. Avoid application on broken skin or areas prone to sensitivity like around the eyes, mouth, or nose unless advised. Always follow up with a broad-spectrum sunscreen during the daytime to prevent photosensitivity and worsening of pigmentation.
Though highly effective, Metaniff HT Cream should not be used for extended periods without a dermatologist’s recommendation, as prolonged use may result in thinning of the skin, acne flare-ups, or rebound pigmentation.